Peer-influenced content. Sources you trust. No registration required. This is HCN.

Trending Topics:
DIET & NUTRITION PATIENT EDUCATION OBESITY/WEIGHT MANAGEMENT EXERCISE/TRAINING LEGAL MATTERS GUIDELINES/RECOMMENDATIONS

Articles related to HYPOTHYROIDISM

Thyroid

American Thyroid Association 2026 Guidelines for Thyroid Disease in Preconception, Pregnancy, and Postpartum

The American Thyroid Association released updated evidence-based recommendations for thyroid disease in preconception, pregnancy, and postpartum, incorporating new trial data on LT4 treatment thresholds, TPOAb management, and ATD safety that diverge meaningfully from 2017 guidance.

Endocrinology, Diabetes, Metabolism June 17th 2026

Tags: AUTOIMMUNE DISORDERS FERTILITY/IVF GUIDELINES/RECOMMENDATIONS HORMONAL HEALTH HYPOTHYROIDISM MATERNAL-FETAL MEDICINE PREGNANCY COMPLICATIONS PRENATAL CARE REPRODUCTIVE ENDOCRINOLOGY THYROID DISEASE

Drugs.com

FDA Upgrades Recall on 160,000+ Bottles of Thyroid Medication

The recall was initiated because the medication content of the recalled pills is ‘below the approved specification’.

Clinical Pharmacology August 22nd 2025

Tags: DRUG SAFETY & INTERACTIONS HEALTHCARE QUALITY HYPOTHYROIDISM PRODUCT RECALL THYROID DISEASE

Cleveland Clinic Journal of Medicine (CCJM)

Treating the Thyroid: Trust the Feedback Loop

“Many factors external to the thyroid gland can modulate these diverse effects, making it difficult to assess the thyroid status of patients solely on clinical grounds.”

Endocrinology, Diabetes, Metabolism March 4th 2025

Tags: HYPOTHYROIDISM TESTING/LABS THYROID DISEASE

ACP Internist

MKSAP Quiz: Follow-up of Hypoparathyroidism

Stay updated with the latest advancements in the management of hypoparathyroidism. Enhance your knowledge and improve patient outcomes by understanding the nuances of diagnosis and treatment.

Endocrinology, Diabetes, Metabolism November 15th 2023

Tags: HYPOTHYROIDISM QUIZZES & QUESTIONS

Medical Professionals Reference (MPR)

Subpotent Oral Solution Prompts Recall of Hypothyroidism Treatment

The oral solution revealed 95% of the labeled amount of levothyroxine sodium (T4) for the affected lots. This recall does not apply to Tirosint capsules.

Endocrinology, Diabetes, Metabolism March 2nd 2023

Tags: HYPOTHYROIDISM PRODUCT RECALL

Topics

Sources

American Journal of Clinical Pathology (AJCP)
American Nurse Journal (ANJ)
Anesthesiology News
Annals of Internal Medicine
British Medical Journal (The BMJ)
Cancer Therapy Advisor
Cardiology Advisor
Cleveland Clinic Journal of Medicine (CCJM)
Clinical Advisor
Conexiant
Consultant360
Cureus
Dermatology Advisor
Endocrinology Advisor
Gastroenterology Advisor
GoodRx for Healthcare Professionals
Healthgrades for Professionals
Hematology Advisor
JNP: The Journal for Nurse Practitioners
Journal of Invasive Cardiology (JIC)
Journal of the American College of Cardiology (JACC)
Journal of the National Cancer Institute (JNCI)
Mayo Clinic
MD Newsline
MDLinx
MedCentral
Medical News Today (MNT)
Medical Professionals Reference (MPR)
Neurology Advisor
Oncology News Central (ONC)
Ophthalmology Advisor
Pharmacy Practice News
Physician’s Weekly
POCN
Practical Neurology
Psychiatrist.com
Psychiatry Advisor
ReachMD
Renal & Urology News
The American Journal of Nursing (AJN)
UCLA Health
WebMD
Women’s Healthcare
The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form